Read more

Silicon Canals reports Caristo's Series A announcement

Oxford-based Caristo Diagnostics bags €14.7M for AI-powered cardiac disease detection; appoints new CEO

Oxford-based Caristo Diagnostics, a company that specialises in cardiac and vascular disease diagnostics and risk prediction, announced on Monday, April…

Read more

Quote by Frank Cheng, CEO, Caristo Diagnostics

Caristo Diagnostics Completes Series A Financing and Welcomes New CEO to Advance Ground-Breaking AI Technology for Cardiac Disease Detection

$16 Million Investment Led by Oxford Science Enterprises and Joined by Multiple Institutional Investors OXFORD, England, April 17, 2023 /PRNewswire/ — Caristo Diagnostics Limited, a global…

Read more

Stever Barclay, Secretary of State for Health and Social Care, UK

AI awards help build evidence base for technologies – health secretary

In an exclusive column for Digital Health News, Secretary of State for Health and Social Care Steve Barclay says the…

Read more

Oxford University


Caristo Diagnostics Caristo Diagnostics is a startup that is using standard CT scans to identify potentially heart-stopping plaques. Their technology…

How can artificial intelligence be used to improve cardiovascular care?

BHF-funded researchers are paving the way towards future breakthroughs in heart disease research. Here are 5 big questions we’re helping…

Read more

AI harnessed for early identification of cardiovascular problems

Cardiovascular disease is the world’s biggest killer, responsible for almost 18m deaths a year, according to the World Health Organization….

Read more

British Heart Foundation: Our research highlights of 2021

From AI technology that can predict heart attacks to a potential new drug for incurable vascular dementia, the BHF has…

Read more

WIRED: The Hottest Startups in Oxford

Oxford is already home to one of the world’s most prestigious universities. Now its startup scene is finally getting the…

View Resources Archive

Get in touch for more information.